Toyotaka Iguchi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Risk of Thrombocytopenia by SSRIs or SNRIs in Patients With Depression Based on MID-NET: A Cohort Study in Japan.
Journal: Clinical and translational science
Published: January 09, 2025
Risk of artery dissection during systemic exposure to vascular endothelial growth factor pathway inhibitors.
Journal: Clinical and translational science
Published: September 03, 2024
Risk of neutropenia in psoriasis patients prescribed anti-IL-23 antibody in comparison with anti-IL-17 antibody or adalimumab based on real-world data from the MID-NET® in Japan.
Journal: The Journal of dermatological treatment
Published: July 04, 2024
PMDA Perspective on RWD/RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage.
Journal: Pharmacoepidemiology and drug safety
Published: March 07, 2024
Increased risk of hypocalcemia with decreased kidney function in patients prescribed bisphosphonates based on real-world data from the MID-NET® in Japan: a new-user cohort study.
Journal: BMC nephrology
Published: January 20, 2024
Prescription trend and lactic acidosis in patients prescribed metformin before and after the revision of package insert for allowing metformin administration to patients with moderately decreased kidney function based on real-world data from MID-NET® in Japan.
Journal: Frontiers in medicine
Published: September 15, 2023
Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children.
Journal: The Lancet regional health. Western Pacific
Published: July 11, 2023
Lower Risks of Gastrointestinal Perforation and Intestinal Obstruction in Patients with Atypical Antipsychotics in Comparison with Typical Antipsychotics Based on Real-World Data from the MID-NET® in Japan.
Journal: Therapeutic innovation & regulatory science
Published: July 09, 2023
Use of National Database of Health Insurance Claims and Specific Health Checkups for examining practical utilization and safety signal of a drug to support regulatory assessment on postmarketing drug safety in Japan.
Journal: Frontiers in medicine
Published: November 13, 2022
Characterizing Granulocytopenia Associated with Thiamazole in Patients with Hyperthyroidism Based on Real-World Data from the MID-NET in Japan.
Journal: Clinical pharmacology and therapeutics
Published: October 04, 2022
Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations.
Journal: The Lancet regional health. Western Pacific
Published: September 26, 2022
Cardiovascular risk of urate-lowering drugs: A study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
Journal: Clinical and translational science
Published: July 06, 2022
Last Updated: 09/26/2026